Transport and Golgi organisation protein 1 is a novel tumour progressive factor in oral squamous cell carcinoma

European Journal of Cancer

Volumn 50, Issue 12, 2014, Pages 2142-2151

  Sasahira, Tomonori ^a   Kirita, Tadaaki ^a   Yamamoto, Kazuhiko ^a   Ueda, Nobuhiro ^a   Kurihara, Miyako ^a   Matsushima, Sayako ^a   Bhawal, Ujjal K ^a,b   Bosserhoff, Anja Katrin ^c   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Angiogenesis; Lymphangiogenesis; MIA; Neuropilin2; Oral cancer; PDGFB; TANGO

Indexed keywords

NEUROPILIN 2; PLATELET DERIVED GROWTH FACTOR B; TRANSPORT AND GOLGI ORGANIZATION PROTEIN 1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER PATIENT; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SQUAMOUS CELL CARCINOMA CELL LINE; TUMOR GROWTH;

ANGIOGENESIS; LYMPHANGIOGENESIS; MIA; NEUROPILIN2; ORAL CANCER; PDGFB; TANGO;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHILINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-SIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84904036772     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.05.006     Document Type: Article

References (52)

1. N. Johnson Tobacco use and oral cancer: a global perspective J Dent Educ 65 4 2001 328 339
2. D.M. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 9 2001 533 543
3. I.C. Paterson, J.W. Eveson, and S.S. Prime Molecular changes in oral cancer may reflect aetiology and ethnic origin Eur J Cancer B Oral Oncol 32B 3 1996 150 153
4. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 1 2007 43 66
5. S. Tanaka, and T. Sobue Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000) Jpn J Clin Oncol 35 8 2005 488 491
6. E.E. Vokes, R.R. Weichselbaum, S.M. Lippman, and W.K. Hong Head and neck cancer N Engl J Med 328 3 1993 184 194
7. D. Wolff, S. Hassfeld, and C. Hofele Influence of marginal and segmental mandibular resection on the survival rate in patients with squamous cell carcinoma of the inferior parts of the oral cavity J Craniomaxillofac Surg 32 5 2004 318 323
8. P.P. Dos Reis, R.R. Bharadwaj, J. Machado, C. Macmillan, M. Pintilie, and M.A. Sukhai et al. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma Cancer 113 11 2008 3169 3180
9. A.K. Bosserhoff, M. Moser, J. Scholmerich, R. Buettner, and C. Hellerbrand Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes J Biol Chem 278 17 2003 15225 15231
10. A.K. Bosserhoff, M. Moser, and R. Buettner Characterization and expression pattern of the novel MIA homolog TANGO Gene Expr Patterns 4 4 2004 473 479
11. C. Hellerbrand, F. Bataille, J. Schlegel, A. Hartmann, M. Muhlbauer, and J. Scholmerich et al. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers Liver Int 25 2 2005 357 366
12. S. Arndt, and A.K. Bosserhoff TANGO is a tumor suppressor of malignant melanoma Int J Cancer 119 12 2006 2812 2820
13. S. Arndt, C. Melle, K. Mondal, G. Klein, F. von Eggeling, and A.K. Bosserhoff Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes J Leukoc Biol 82 6 2007 1466 1472
14. S. Arndt, and A.K. Bosserhoff Reduced expression of TANGO in colon and hepatocellular carcinomas Oncol Rep 18 4 2007 885 891
15. C. Hellerbrand, T. Amann, J. Schlegel, P. Wild, F. Bataille, and T. Spruss et al. The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma Gut 57 2 2008 243 251
16. I. Poser, M. Golob, R. Buettner, and A.K. Bosserhoff Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype Mol Cell Biol 23 8 2003 2991 2998
17. T. Sasahira, T. Kirita, N. Oue, U.K. Bhawal, K. Yamamoto, and K. Fujii et al. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma Cancer Sci 99 9 2008 1806 1812
18. A.K. Bosserhoff, M. Kaufmann, B. Kaluza, I. Bartke, H. Zirngibl, and R. Hein et al. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma Cancer Res 57 15 1997 3149 3153
19. A.K. Bosserhoff, R. Stoll, J.P. Sleeman, F. Bataille, R. Buettner, and T.A. Holak Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity Lab Invest 83 11 2003 1583 1594
20. A. Winklmeier, V. Contreras-Shannon, S. Arndt, C. Melle, and A.K. Bosserhoff Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration Cancer Sci 100 2 2009 261 268
21. P.P. Aung, N. Oue, Y. Mitani, H. Nakayama, K. Yoshida, and T. Noguchi et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer Oncogene 25 17 2006 2546 2557
22. A.K. Bosserhoff, M. Moser, R. Hein, M. Landthaler, and R. Buettner In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers J Pathol 187 4 1999 446 454
23. A.K. Bosserhoff, S. Kondo, M. Moser, U.H. Dietz, N.G. Copeland, and D.J. Gilbert et al. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma Dev Dyn 208 4 1997 516 525
24. P. Hau, P. Ruemmele, L.A. Kunz-Schughart, A. Doerfelt, B. Hirschmann, and A. Lohmeier et al. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma Oncol Rep 12 6 2004 1355 1364
25. J. El Fitori, J. Kleeff, N.A. Giese, A. Guweidhi, A.K. Bosserhoff, and M.W. Buchler et al. Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells Cancer Cell Int 5 1 2005 3
26. T. Sasahira, T. Kirita, M. Kurihara, K. Yamamoto, U.K. Bhawal, and A.K. Bosserhoff et al. MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma Eur J Cancer 46 12 2010 2285 2294
27. A.K. Bosserhoff, and R. Buettner Expression, function and clinical relevance of MIA (melanoma inhibitory activity) Histol Histopathol 17 1 2002 289 300
28. M. Kurihara, T. Kirita, T. Sasahira, H. Ohmori, S. Matsushima, and K. Yamamoto et al. Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma Br J Cancer 108 7 2013 1460 1469
29. T. Sasahira, T. Kirita, U.K. Bhawal, K. Yamamoto, H. Ohmori, and K. Fujii et al. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma Histopathology 51 2 2007 166 172
30. S. Suzuki, Y. Dobashi, Y. Hatakeyama, R. Tajiri, T. Fujimura, and C.H. Heldin et al. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-beta phosphorylation, and microvessel density in gastric cancer BMC Cancer 10 2010 659
31. M. Kodama, Y. Kitadai, T. Sumida, M. Ohnishi, E. Ohara, and M. Tanaka et al. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor beta is associated with lymphatic metastasis in human gastric carcinoma Cancer Sci 101 9 2010 1984 1989
32. R. Cao, M.A. Bjorndahl, P. Religa, S. Clasper, S. Garvin, and D. Galter et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis Cancer Cell 6 4 2004 333 345
33. H. Sano, J.P. Leboeuf, S.V. Novitskiy, S. Seo, S. Zaja-Milatovic, and M.M. Dikov et al. The Foxc2 transcription factor regulates tumor angiogenesis Biochem Biophys Res Commun 392 2 2010 201 206
34. S.L. Dagenais, R.L. Hartsough, R.P. Erickson, M.H. Witte, M.G. Butler, and T.W. Glover Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome Gene Expr Patterns 4 6 2004 611 619
35. E. Fagiani, P. Lorentz, L. Kopfstein, and G. Christofori Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis Cancer Res 71 17 2011 5717 5727
36. J. Kazenwadel, M.Z. Michael, and N.L. Harvey Prox1 expression is negatively regulated by miR-181 in endothelial cells Blood 116 13 2010 2395 2401
37. G.G. Van den Eynden, I. Van der Auwera, S.J. Van Laere, X.B. Trinh, C.G. Colpaert, and P. van Dam et al. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer J Pathol 213 1 2007 56 64
38. W.H. Kim, S.H. Lee, M.H. Jung, J.H. Seo, J. Kim, and M.A. Kim et al. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF Exp Cell Res 315 13 2009 2154 2164
39. F.J. Lin, X. Chen, J. Qin, Y.K. Hong, M.J. Tsai, and S.Y. Tsai Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development J Clin Invest 120 5 2010 1694 1707
40. T. Sasahira, N. Oue, T. Kirita, Y. Luo, U.K. Bhawal, and K. Fujii et al. Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland Histopathology 53 6 2008 667 675
41. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 2 1998 155 168
42. T. Sasahira, M. Kurihara, K. Yamamoto, U.K. Bhawal, T. Kirita, and H. Kuniyasu Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland Cancer Sci 102 2 2011 492 497
43. R. Stoll, C. Renner, M. Zweckstetter, M. Bruggert, D. Ambrosius, and S. Palme et al. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold EMBO J 20 3 2001 340 349
44. R. Bauer, M. Humphries, R. Fassler, A. Winklmeier, S.E. Craig, and A.K. Bosserhoff Regulation of integrin activity by MIA J Biol Chem 281 17 2006 11669 11677
45. H. Yasuoka, R. Kodama, M. Tsujimoto, K. Yoshidome, H. Akamatsu, and M. Nakahara et al. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression BMC Cancer 9 2009 220
46. N.A. Dallas, M.J. Gray, L. Xia, F. Fan, G. van Buren 2nd, and P. Gaur Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma Clin Cancer Res 14 24 2008 8052 8060
47. C. Grandclement, J.R. Pallandre, S. Valmary Degano, E. Viel, A. Bouard, and J. Balland et al. Neuropilin-2 expression promotes TGF-beta1-mediated epithelial to mesenchymal transition in colorectal cancer cells PLoS One 6 7 2011 e20444
48. I. Helfrich, L. Edler, A. Sucker, M. Thomas, S. Christian, and D. Schadendorf et al. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma Clin Cancer Res 15 4 2009 1384 1392
49. H. Huang, J.Y. Lai, J. Do, D. Liu, L. Li, and J. Del Rosario et al. Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth Clin Cancer Res 17 5 2011 1001 1011
50. T. Sasahira, N. Ueda, K. Yamamoto, M. Kurihara, S. Matsushima, and U.K. Bhawal et al. Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma PLoS One 9 3 2014 e92534
51. R.K. Jain, L.L. Munn, and D. Fukumura Dissecting tumour pathophysiology using intravital microscopy Nat Rev Cancer 2 4 2002 266 276
52. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 5706 2005 58 62